Vulinacimab, CAS [[2250342-36-8]]

Produktübersicht

• Artikelname: Vulinacimab, CAS [[2250342-36-8]]
• Artikelnummer: MCE-HY-P99516
• Hersteller Artikelnummer: HY-P99516
• Alternativnummer: MCE-HY-P99516-1MG,MCE-HY-P99516-5MG,MCE-HY-P99516-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: HLX-06

Produktbeschreibung

Vulinacimab (HLX-06) is a human monoclonal antibody directed against human vascular endothelial growth factor receptor 2 (VEGFR-2). Vulinacimab specifically binds to and inhibits VEGFR-2, which may inhibit tumor angiogenesis and tumor cell proliferation. Vulinacimab can be used for the research of solid tumors and non-small cell lung cancer[1].

Produkteigenschaften

• Molekulargewicht: (145.28 kDa)
• Reinheit: 99.96
• CAS Nummer: [2250342-36-8]
• Target-Kategorie: VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies